MDT Stock Risk & Deep Value Analysis
Medtronic PLC
Healthcare • Medical Devices
DVR Score
out of 10
The Bottom Line on MDT
We analyzed Medtronic PLC using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran MDT through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.
📈MDT Performance Overview3yr weekly
Unlock MDT Performance Chart
See 3 years of price history, quarterly revenue trends, and DVR score changes
Weekly adjusted close · Quarterly revenue & EPS · DVR score history
MDT Stock Risk Analysis
Overall Risk
Moderate
Financial Risk
Low
Market Risk
Medium
About Medtronic PLC (MDT)
Sector
Healthcare
Industry
Medical Devices
Market Cap Category
large
Market Cap
$130.42B
MDT Deep Value Analysis
MDT Red Flags & Warning Signs
Premium- ⚠
Increased regulatory scrutiny or delays in product approvals
- ⚠
Major product recall or adverse event reporting
- ⚠
Intensified competitive pressure from innovative startups or larger rivals
Unlock MDT Red Flags & Risk Warnings
Premium members see every risk event we found.
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
Unlock everything for $47/yr
$79/yrSave 41%
- ✓ Catalysts, bull case, moat & red flags
- ✓ Unlimited stock analyses + alerts
- ✓ Full database, search & portfolio (50 stocks)
7-day money back · Cancel anytime
MDT Financial Health Metrics
Market Cap
$130.42B
P/E Ratio
28.09
MDT Competitive Moat Analysis
PremiumMoat Rating
Wide
Moat Trend
Stable
Moat Sources
4 Identified
Medtronic's moat is highly durable, stemming from its vast patent estate, the complex and lengthy regulatory approval processes for medical devices, deeply entrenched relationships with healthcare providers, and the high cost/risk associated with switching critical medical equipment.
MDT Competitive Moat Analysis
Premium unlocks moat rating, sources & durability.
MDT Catalysts & Growth Drivers
Near-Term (0-6 months)
- •Q4 Fiscal Year 2026 Earnings Report (Estimated Early-May 2026)
- •New product launches or expanded indications in high-growth areas (e.g., diabetes, neuromodulation)
- •Positive clinical trial data for pipeline devices
Medium-Term (6-18 months)
- •Expansion into new emerging markets for key product lines
- •Strategic bolt-on acquisitions to strengthen existing segments
- •Advancements in AI/digital health integration across device platforms
Long-Term (18+ months)
- •Aging global population driving demand for medical devices
- •Increased adoption of minimally invasive surgical techniques
- •Technological advancements enabling personalized healthcare solutions
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
MDT Bull Case: What Could Go Right
- ✓
Consistent execution on R&D pipeline and new product launches
- ✓
Stable or expanding operating margins in a competitive environment
- ✓
Any signs of accelerating organic revenue growth beyond historical single-digit rates
Bull Case Analysis
See what could go right with Premium
Never miss a move on MDT
Create a free account to set price alerts and get notified on Telegram when MDT hits your targets.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.
FAQ
What is the DVR Score for Medtronic PLC (MDT)?
As of March 19, 2026, Medtronic PLC has a DVR Score of 0.1 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Medtronic PLC?
Medtronic PLC's market capitalization is approximately $130.4B. The company operates in the Healthcare sector within the Medical Devices industry.
What ticker symbol does Medtronic PLC use?
MDT is the ticker symbol for Medtronic PLC. The company trades on the NYQ.
What is the risk level for MDT stock?
Our analysis rates Medtronic PLC's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of MDT?
Medtronic PLC currently has a price-to-earnings (P/E) ratio of 28.1. This is in line with broader market averages.
Does Medtronic PLC pay a dividend?
Yes, Medtronic PLC pays a dividend with a current yield of approximately 295.00%.
How often is the MDT DVR analysis updated?
Our AI-powered analysis of Medtronic PLC is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 19, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.